NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
28.19
-0.53 (-1.85%)
Apr 29, 2026, 2:14 PM EDT - Market open
NAMS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Net Income | -203.82 | -241.6 | -176.94 | -22.63 | -41.79 | Upgrade
|
| Depreciation & Amortization | 0.22 | 0.11 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Other Amortization | - | - | - | - | 0.16 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 8 | 7.22 | Upgrade
|
| Stock-Based Compensation | 59.43 | 33.62 | 24.57 | 4.12 | 1.24 | Upgrade
|
| Other Operating Activities | 4.32 | 81.98 | 5.23 | 10.8 | -0.82 | Upgrade
|
| Change in Accounts Payable | 4.91 | -12.95 | 5.07 | 4.81 | 6.56 | Upgrade
|
| Change in Unearned Revenue | -2.02 | -3.95 | -8.71 | 18.43 | - | Upgrade
|
| Change in Other Net Operating Assets | -10.83 | -15.77 | 9.5 | -12.86 | -2.09 | Upgrade
|
| Operating Cash Flow | -147.78 | -158.56 | -141.22 | 10.67 | -29.51 | Upgrade
|
| Capital Expenditures | -0.25 | -0.67 | -0.02 | -0.22 | -0.02 | Upgrade
|
| Investment in Securities | -174.67 | -62.18 | - | - | - | Upgrade
|
| Investing Cash Flow | -174.92 | -62.85 | -0.02 | -0.22 | -0.02 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 0.75 | - | Upgrade
|
| Total Debt Issued | - | - | - | 0.75 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 0.75 | - | Upgrade
|
| Issuance of Common Stock | 31.11 | 661.04 | 8.91 | 396.95 | - | Upgrade
|
| Repurchase of Common Stock | - | -0.99 | - | - | - | Upgrade
|
| Other Financing Activities | -1.59 | -0.54 | - | -5.79 | - | Upgrade
|
| Financing Cash Flow | 29.52 | 659.51 | 8.91 | 391.91 | 84.7 | Upgrade
|
| Foreign Exchange Rate Adjustments | 12.76 | -6.8 | 5.05 | 5.25 | -4.68 | Upgrade
|
| Net Cash Flow | -280.42 | 431.29 | -127.28 | 407.6 | 50.49 | Upgrade
|
| Free Cash Flow | -148.03 | -159.24 | -141.24 | 10.44 | -29.54 | Upgrade
|
| Free Cash Flow Margin | -657.82% | -349.49% | -1002.43% | 10.17% | - | Upgrade
|
| Free Cash Flow Per Share | -1.25 | -1.69 | -1.72 | 0.55 | -2.69 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.28 | - | Upgrade
|
| Cash Income Tax Paid | - | 0 | 0.03 | - | - | Upgrade
|
| Levered Free Cash Flow | -112.91 | -43.17 | -72 | 22.7 | -15.94 | Upgrade
|
| Unlevered Free Cash Flow | -112.91 | -43.17 | -72 | 22.88 | -15.84 | Upgrade
|
| Change in Working Capital | -7.94 | -32.67 | 5.87 | 10.37 | 4.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.